Common use of EXAMPLE ROYALTY REPORT Clause in Contracts

EXAMPLE ROYALTY REPORT. Required royalty report information includes: • XXX license reference number (L-XXX-200X/0) • Reporting period • Catalog number and units sold of each Licensed Product (domestic and foreign) • Gross Sales per catalog number per country • Total Gross Sales • Itemized deductions from Gross Sales • Total Net Sales • Earned Royalty Rate and associated calculations • Gross Earned Royalty • Adjustments for Minimum Annual Royalty (MAR) and other creditable payments made • Net Earned Royalty due Example Catalog Number Product Name Country Units Sold Gross Sales (US$) 1 A US 250 62,500 1 A UK 32 16,500 1 A France 25 15,625 2 B US 0 0 3 C US 57 57,125 4 D US 12 1,500 Total Gross Sales 153,250 Less Deductions: Freight 3,000 Returns 7,000 Total Net Sales 143,250 Royalty Rate 8% Royalty Due 11,460 Less Creditable Payments 10,000 Net Royalty Due 1,460 A-293-2011 CONFIDENTIAL PHS Patent License Agreement—Exclusive Model 10-2005 (updated 4-2010) Page 26 of 28 [Final] [GlobeImmune, Inc] [December 7, 2011] SV\805701.4 GlobeImmune – Patent Lic. Agt. (Exclusive) – PHS (jointly owned ip) [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

EXAMPLE ROYALTY REPORT. Required royalty report information includes: • XXX license reference number (L-XXX-200X/0) • Reporting period • Catalog number and units sold of each Licensed Product (domestic and foreign) • Gross Sales per catalog number per country • Total Gross Sales • Itemized deductions from Gross Sales • Total Net Sales • Earned Royalty Rate and associated calculations • Gross Earned Royalty • Adjustments for Minimum Annual Royalty (MAR) and other creditable payments made • Net Earned Royalty due Example Catalog Number Product Name Country Units Sold Gross Sales (US$) 1 A US 250 62,500 1 A UK 32 16,500 1 A France 25 15,625 2 B US 0 0 3 C US 57 57,125 4 D US 12 1,500 Total Gross Sales 153,250 Less Deductions: Freight 3,000 Returns 7,000 Total Net Sales 143,250 Royalty Rate 88 % Royalty Due 11,460 Less Creditable Payments 10,000 Net Royalty Due 1,460 A-293A-343-2011 2009 CONFIDENTIAL PHS Patent License Agreement—Exclusive Model 10-2005 (updated 4-2010) Page 26 of 28 [Final] [GlobeImmune, Inc] [December 7August 19, 2011] SV\805701.4 GlobeImmune – Patent Lic. Agt. (Exclusive) – PHS (jointly owned ip) [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

EXAMPLE ROYALTY REPORT. Required royalty report information includes: • XXX license License reference number (L-XXX-200X/0) • Reporting period • Catalog number and units sold of each Licensed Product (domestic and foreign) • Gross Sales per catalog number per country • Total Gross Sales • Itemized deductions from Gross Sales • Total Net Sales • Earned Royalty Rate and associated calculations • Gross Earned Royalty • Adjustments for Minimum Annual Royalty (MAR) and other creditable payments made • Net Earned Royalty due Example Catalog Number Product Name Country Units Sold Gross Sales (US$) 1 A US 250 62,500 1 A UK 32 16,500 1 A France 25 15,625 2 B US 0 0 3 C US 57 57,125 4 D US 12 1,500 Total Gross Sales 153,250 Less Deductions: Freight 3,000 Returns 7,000 Total Net Sales 143,250 Royalty Rate 8% Royalty Due 11,460 Less Creditable Payments 10,000 Net Royalty Due 1,460 A-293-2011 CONFIDENTIAL PHS Patent License Agreement—Exclusive Model 10-2005 (updated 4-2010) Page 26 [***] Portions of 28 this exhibit have been redacted pursuant to a Confidential Treatment Request. An unredacted version of this exhibit has been filed separately with the Commission. APPENDIX G – ROYALTY PAYMENT OPTIONS [Final***] [GlobeImmune, Inc] [December 7, 2011] SV\805701.4 GlobeImmune – Patent Lic. Agt. (Exclusive) – PHS (jointly owned ip) [***] = Certain confidential information contained in Portions of this document, marked by brackets, is filed with the Securities and Exchange Commission exhibit have been redacted pursuant to Rule 406 of the Securities Act of 1933, as amended.a Confidential Treatment Request. An